Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre

References

• Finnish Cancer Registry. Available from: http://www.cancerregistry.fi/eng/statistics/.
   Google Scholar
• Liedberg F, Månsson W. Lymph node metastasis in bladder cancer. Eur Urol 2006; 49: 13–21
   PubMed Web of Science ®Google Scholar
• Sternberg C, Donat S, Bellmunt J, Millikan R, Stadler W, De Mulder P, et al. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 2007; 69((1 Suppl))62–79
   PubMedGoogle Scholar
• Herr H, Dotan Z, Donat S, Bajorin D. Defining optimal therapy for muscle invasive bladder cancer. J Urol 2007; 177: 437–43
   PubMed Web of Science ®Google Scholar
• Boström, P, Kössi, J, Laato, M, Nurmi M. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2008; July.
   PubMed Web of Science ®Google Scholar
• Sobin, LH, Wittekind, C. UICC. 2002. TNM classification of malignant tumors. 6th ed. New York: Wiley and Sons; 2002.
   Google Scholar
• Mostofi FK, Sobin LH. Histologic typing of urinary bladder tumors. World Health Organization, Geneva 1973
   Google Scholar
• Hautmann R, Gschwend J, de Petriconi R, Kron M, Volkmer B. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006; 176: 486–92
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Hochreiter W, Burkhard F, Thalmann G, Danuser H, Markwalder R, et al. Radical cystectomy for bladder cancer today – a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 21: 690–6
   PubMed Web of Science ®Google Scholar
• Stein J, Lieskovsky G, Cote R, Groshen S, Feng A, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666–75
   PubMed Web of Science ®Google Scholar
• Shariat S, Karakiewicz P, Palapattu G, Lotan Y, Rogers C, Amiel G, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414–22
   PubMed Web of Science ®Google Scholar
• Dhar N, Klein E, Reuther A, Thalmann G, Madersbacher S, Studer U. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179: 873–8
   PubMed Web of Science ®Google Scholar
• Brausi M. The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer. Eur Urol 2007; 51: 1435–6
   PubMed Web of Science ®Google Scholar
• Whelan P. The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer. Eur Urol 2007; 51: 1436–7
   PubMed Web of Science ®Google Scholar
• Stroumbakis N, Herr H, Cookson M, Fair W. Radical cystectomy in the octogenarian. J Urol 1997; 158: 2113–7
   PubMed Web of Science ®Google Scholar
• Soulié M, Straub M, Gamé X, Seguin P, De Petriconi R, Plante P, et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol 2002; 167: 1325–8
   PubMed Web of Science ®Google Scholar
• Clark P, Stein J, Groshen S, Cai J, Miranda G, Lieskovsky G, et al. Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer 2005; 104: 36–43
   PubMed Web of Science ®Google Scholar
• Sved P, Gomez P, Nieder A, Manoharan M, Kim S, Soloway M. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors. BJU Int 2004; 94: 785–9
   PubMed Web of Science ®Google Scholar
• Nieder A, Sved P, Gomez P, Kim S, Manoharan M, Soloway M. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring. Urology 2004; 64: 950–4
   PubMed Web of Science ®Google Scholar
• Huguet J, Monllau V, Sabaté S, Rodriguez-Faba O, Algaba F, Palou J, et al. Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur Urol 2008; 53: 785–92
   PubMed Web of Science ®Google Scholar
• Volkmer BG, Bartsch G, Kuefer R, Hautmann RE. Oncologic follow-up after radical cystectomy: is there any benefit?. J Urol 2008; 179: 582
   PubMed Web of Science ®Google Scholar
• Dhar N, Klein E, Reuther A, Thalmann G, Madersbacher S, Studer U. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179: 873–8
   PubMed Web of Science ®Google Scholar
• Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 1999;354:533–40.
   PubMed Web of Science ®Google Scholar
• Winquist E, Kirchner T, Segal R, Chin J, Lukka H. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. J Urol 2004; 171: 561–9
   PubMed Web of Science ®Google Scholar
• Shariat S, Karakiewicz P, Ashfaq R, Lerner S, Palapattu G, Cote R, et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008; 112: 315–25
   PubMed Web of Science ®Google Scholar